Category

Archives

PDPK1

MiR-139 Affects Radioresistance in Esophageal Cancer by Targeting the PDK1/AKT/Cyclin D1 Signaling Pathway

43 views | May 21 2023

MiR-139 enhances radiosensitivity in esophageal cancer by regulating the cell cycle through the PDK1/Akt/Cyclin D1 signaling pathway, according to a study using KYSE150R cells and clinical data from 110 EC patients. [Read the Full Post]

Combined femoral and acetabular version is sex-related and differs between patients with hip dysplasia and acetabular retroversion

51 views | Jan 16 2023

Malin K Meier et al. found that patients with DDH and AR had remarkable sex-related differences of FV and CV. [Read the Full Post]

A simple protein histidine kinase activity assay for high-throughput inhibitor screening

94 views | Jan 16 2023

Donghee Lee et al. identified OSU-03012, a potent VanS HK inhibitor, which sensitized VRE toward vancomycin, highlighting the potential of AUDECY in HK inhibitor discovery. [Read the Full Post]